sellWeak cluster of 610b5-1 plan
Todd Berard sold $7,200 of BLFS
Chief Marketing Officer at BIOLIFE SOLUTIONS INC. 311 shares at an average of $23.15, traded Oct 30, 2024, filed Nov 1, 2024.
Warning score
10Value
$7,200
311 shares
Holdings after
107,847
-0% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- 0Trade size$7k at market
- 0Share of holdings soldSold 0.3% of holdings
- +15Cluster6 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001628280-24-044814, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 30, 2024 | SOpen-market sale Common Stock10b5-1 | -311 | $23.15 | $7,200 | 107,847 | Nov 1, 2024 |
Related signals
Other insiders at BIOLIFE SOLUTIONS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | BIOLIFE SOLUTIONS INC | Sarah Aebersold Chief Human Resources Officer | $23k 946 shares | -1% | |
| 10Weak | BIOLIFE SOLUTIONS INC | Karen A. Foster Chief Quality and Operations | $13k 519 shares | -0% | |
| 10Weak | BIOLIFE SOLUTIONS INC | Todd Berard Chief Marketing Officer | $8,997 358 shares | -0% | |
| 37Weak | BIOLIFE SOLUTIONS INC | Amy DuRoss director | $49k 2,000 shares | -10% | |
| 22Weak | BIOLIFE SOLUTIONS INC | Troy Wichterman Chief Financial Officer | $26k 1,033 shares | -1% | |
| 10Weak | BIOLIFE SOLUTIONS INC | Aby J. Mathew EVP & Chief Scientific Officer | $16k 631 shares | -0% | |
| 64Notable | BIOLIFE SOLUTIONS INC | Troy Wichterman Chief Financial Officer | $772k 30,000 shares | -16% | |
| 10Weak | BIOLIFE SOLUTIONS INC | Sarah Aebersold Chief Human Resources Officer | $5,803 217 shares | -0% | |
| 10Weak | BIOLIFE SOLUTIONS INC | Aby J. Mathew EVP & Chief Scientific Officer | $14k 526 shares | -0% | |
| 10Weak | BIOLIFE SOLUTIONS INC | Sean Werner Chief Technology Officer | $2,941 110 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.